{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T11:36:12Z","timestamp":1759577772899,"version":"3.40.3"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.peptides.2012.09.011","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T09:19:13Z","timestamp":1348046353000},"page":"275-281","source":"Crossref","is-referenced-by-count":13,"title":["Antioxidant activity of vasoactive intestinal peptide in HK2 human renal cells"],"prefix":"10.1016","volume":"38","author":[{"given":"Eva","family":"Vacas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Bajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew V.","family":"Schally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"S\u00e1nchez-Chapado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"Carmena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2012.09.011_bib0005","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000139097","article-title":"Effect of vasoactive intestinal peptide and naloxone combination on urinary N-acetyl-beta-d-glucosaminidase level and kidney histology of rats exposed to severe hemorrhage","volume":"47","author":"Akin","year":"1993","journal-title":"Pharmacology"},{"key":"10.1016\/j.peptides.2012.09.011_bib0010","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2005-03-1186","article-title":"Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury","volume":"107","author":"Arimura","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.peptides.2012.09.011_bib0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.peptides.2012.09.011_bib0020","first-page":"L151","article-title":"Vasoactive intestinal peptide prevents lung injury due to xanthine\/xanthine oxidase","volume":"259","author":"Berisha","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.peptides.2012.09.011_bib0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2008.09.035","article-title":"PACAP and VIP prevent apoptosis in schwannoma cells","volume":"1241","author":"Castorina","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2012.09.011_bib0030","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1098\/rstb.2005.1757","article-title":"Free radicals and the pancreatic acinar cells: role in physiology and pathology","volume":"360","author":"Chvanov","year":"2005","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.peptides.2012.09.011_bib0035","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.peptides.2007.04.015","article-title":"Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model","volume":"28","author":"Collado","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2012.09.011_bib0040","first-page":"1629","article-title":"Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: antagonistic action of a growth-hormone-releasing hormone analog","volume":"26","author":"Collado","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.peptides.2012.09.011_bib0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.regpep.2004.01.013","article-title":"Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells","volume":"119","author":"Collado","year":"2004","journal-title":"Regul Pept"},{"key":"10.1016\/j.peptides.2012.09.011_bib0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1476-5381.2011.01676.x","article-title":"VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins","volume":"166","author":"Couvineau","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2012.09.011_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(99)00421-5","article-title":"Role of oxidative stress in the pathogenesis of caerulein-induced acute pancreatitis","volume":"377","author":"Dabrowski","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2012.09.011_bib0060","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/glia.20681","article-title":"Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels","volume":"56","author":"Delgado","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.peptides.2012.09.011_bib0065","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1189\/jlb.0507327","article-title":"VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP\/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1","volume":"83","author":"El Zein","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.peptides.2012.09.011_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2010.07.019","article-title":"Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1","volume":"299","author":"Fern\u00e1ndez-Mart\u00ednez","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.peptides.2012.09.011_bib0075","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/pros.20930","article-title":"Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells","volume":"69","author":"Fern\u00e1ndez-Mart\u00ednez","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.peptides.2012.09.011_bib0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2007.01.007","article-title":"Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines. Differential time-dependent responses in cancer progression","volume":"270","author":"Fern\u00e1ndez-Mart\u00ednez","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.peptides.2012.09.011_bib0085","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2337\/db08-0057","article-title":"Oxidative stress as a major culprit in kidney disease in diabetes","volume":"57","author":"Forbes","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2012.09.011_bib0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cyto.2006.11.005","article-title":"Vasoactive intestinal peptide (VIP) prevents killing of virulent and phoP mutant Salmonella typhimurium by inhibiting IFN-gamma stimulated NADPH oxidative pathways in murine macrophages","volume":"36","author":"Foster","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.peptides.2012.09.011_bib0095","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.peptides.2011.08.027","article-title":"Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase","volume":"32","author":"Fujimori","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2012.09.011_bib0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12031-010-9428-8","article-title":"Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells","volume":"43","author":"Horvath","year":"2011","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.peptides.2012.09.011_bib0105","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.transproceed.2010.05.015","article-title":"Mice deficient in neuropeptide PACAP demonstrate increased sensitivity to in vitro kidney hypoxia","volume":"42","author":"Horvath","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.peptides.2012.09.011_bib0110","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0022-3565(25)39031-2","article-title":"Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium","volume":"268","author":"Kalfin","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2012.09.011_bib0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000236383","article-title":"Inhibitory effects of vasoactive intestinal peptide on superoxide anion formation by N-formyl-methionyl-leucyl-phenylalanine-activated inflammatory cells in vitro","volume":"100","author":"Kurosawa","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.peptides.2012.09.011_bib0120","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.peptides.2007.04.026","article-title":"Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology","volume":"28","author":"Laburthe","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2012.09.011_bib0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/ars.2008.2109","article-title":"Role of oxidative stress in pancreatic inflammation","volume":"11","author":"Leung","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.peptides.2012.09.011_bib0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.regpep.2007.09.012","article-title":"Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases","volume":"145","author":"Li","year":"2008","journal-title":"Regul Pept"},{"issue":"26","key":"10.1016\/j.peptides.2012.09.011_bib0135","doi-asserted-by":"crossref","first-page":"15371","DOI":"10.1016\/S0021-9258(18)55404-1","article-title":"Vasoactive intestinal peptide, a singlet oxygen quencher","volume":"265","author":"Misra","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2012.09.011_bib0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1749-6632.1994.tb36767.x","article-title":"VIP enhances and nitric oxide synthase inhibitor reduces survival of rat lungs perfused ex vivo","volume":"723","author":"Pakbaz","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.peptides.2012.09.011_bib0145","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/00313020802436402","article-title":"Phosphorylation of caveolin-1 is anti-apoptotic and promotes cell attachment during oxidative stress of kidney cells","volume":"40","author":"Percy","year":"2008","journal-title":"Pathology"},{"key":"10.1016\/j.peptides.2012.09.011_bib0150","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1210\/en.141.6.2120","article-title":"Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers","volume":"141","author":"Rekasi","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2012.09.011_bib0155","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1749-6632.2000.tb06975.x","article-title":"The Viktor Mutt memorial lecture. Protection by VIP and related peptides against cell death and tissue injury","volume":"921","author":"Said","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.peptides.2012.09.011_bib0160","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0306-4522(95)00021-A","article-title":"N-methyl-d-aspartate receptors outside the central nervous system: activation causes acute lung injury that is mediated by nitric oxide synthesis and prevented by vasoactive intestinal peptide","volume":"65","author":"Said","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2012.09.011_bib0165","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.169.3951.1217","article-title":"Polypeptide with broad biological activity: isolation from small intestine","volume":"169","author":"Said","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.peptides.2012.09.011_bib0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1440-1797.2012.01572.x","article-title":"Oxidative stress, anti-oxidant therapies and chronic kidney disease","volume":"17","author":"Small","year":"2012","journal-title":"Nephrology"},{"key":"10.1016\/j.peptides.2012.09.011_bib0175","first-page":"1223","article-title":"Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: antagonistic action of an analog of growth-hormone-releasing hormone","volume":"31","author":"Sotomayor","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.peptides.2012.09.011_bib0180","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1749-6632.1996.tb17509.x","article-title":"Protection of rat retina from ischemia-reperfusion injury by vasoactive intestinal peptide (VIP): the effect of VIP on lipid peroxidation and antioxidant enzyme activity of retina and choroid","volume":"805","author":"Tun\u00e7el","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.peptides.2012.09.011_bib0185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0196-9781(96)00289-6","article-title":"Ischemic-reperfused rat skeletal muscle: the effect of vasoactive intestinal peptide (VIP) on contractile force, oxygenation and antioxidant enzyme systems","volume":"18","author":"Tun\u00e7el","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2012.09.011_bib0190","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1749-6632.1998.tb11191.x","article-title":"The protective effect of vasoactive intestinal peptide (VIP) on stress-induced gastric ulceration in rats","volume":"865","author":"Tun\u00e7el","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.peptides.2012.09.011_bib0195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12031-011-9618-z","article-title":"Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum","volume":"46","author":"Tun\u00e7el","year":"2012","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.peptides.2012.09.011_bib0200","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0196-9781(95)00055-O","article-title":"The effect of vasoactive intestinal peptide (VIP) on superoxide dismutase and catalase activities in renal tissues of rats exposed to hemorrhagic ischemia-reperfusion","volume":"16","author":"Uzuner","year":"1995","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2012.09.011_bib0205","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.bbamcr.2012.06.018","article-title":"Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation","volume":"1823","author":"Vacas","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.peptides.2012.09.011_bib0210","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.peptides.2010.07.024","article-title":"Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer","volume":"31","author":"Valdehita","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2012.09.011_bib0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mce.2008.11.024","article-title":"Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells","volume":"302","author":"Valdehita","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.peptides.2012.09.011_bib0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mce.2011.08.031","article-title":"RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells","volume":"348","author":"Valdehita","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.peptides.2012.09.011_bib0225","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1073\/pnas.96.2.692","article-title":"Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities","volume":"96","author":"Varga","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.peptides.2012.09.011_bib0230","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainres.2011.05.007","article-title":"Vasoactive intestinal peptide protects against ischemic brain damage induced by focal cerebral ischemia in rats","volume":"1398","author":"Yang","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2012.09.011_bib0235","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1681\/ASN.2005111155","article-title":"ATF3 protects against renal ischemia-reperfusion injury","volume":"19","author":"Yoshida","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.peptides.2012.09.011_bib0240","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.peptides.2010.11.017","article-title":"Anti-hyperglycemic, antioxidant and anti-inflammatory effects of VIP and a VPAC1 agonist on streptozotocin-induced diabetic mice","volume":"32","author":"Yu","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2012.09.011_bib0245","doi-asserted-by":"crossref","first-page":"25811","DOI":"10.1371\/journal.pone.0025811","article-title":"Preconditioning with physiological levels of ethanol protect kidney against ischemia\/reperfusion injury by modulating oxidative stress","volume":"6","author":"Yuan","year":"2011","journal-title":"PLoS One"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978112003968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978112003968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:09:48Z","timestamp":1744160988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978112003968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0196978112003968"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2012.09.011","relation":{},"ISSN":["0196-9781"],"issn-type":[{"type":"print","value":"0196-9781"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}